公开(公告)号：US11615160B2

公开(公告)日：2023-03-28

申请号：US17242770

申请日：2021-04-28

Applicant: IQVIA Inc.

Inventor： Gary Shorter ,  Jaffershah Jahangeer

IPC: G06F16/955 ,  G16H20/00 ,  G06K7/14 ,  G06K19/06

Abstract: Embodiments of the present disclosure provide a method for monitoring/tracking the lifecycle of a drug from build (e.g., as part of clinical trial development), to approval (e.g., regulatory), to in-market (e.g., distribution and safety information). The use of artificial intelligence (AI) and blockchain technology may enable the system to track the drug down to the prescription level and may support a digital label that can be updated as necessary based on such monitoring (e.g., that can be amended based on safety information detected while the drug is in market and warnings sent out upon amendment).

公开(公告)号：US20230281261A1

公开(公告)日：2023-09-07

申请号：US18189393

申请日：2023-03-24

Applicant: IQVIA Inc.

Inventor： Gary Shorter ,  Jaffershah Jahangeer

IPC: G06F16/955 ,  G16H20/00 ,  G06K7/14 ,  G06K19/06

CPC classification number: G06F16/9554 ,  G16H20/00 ,  G06K7/1417 ,  G06K19/06009

Abstract: Embodiments of the present disclosure provide a method for monitoring/tracking the lifecycle of a drug from build (e.g., as part of clinical trial development), to approval (e.g., regulatory), to in-market (e.g., distribution and safety information). The use of artificial intelligence (AI) and blockchain technology may enable the system to track the drug down to the prescription level and may support a digital label that can be updated as necessary based on such monitoring (e.g., that can be amended based on safety information detected while the drug is in market and warnings sent out upon amendment).

公开(公告)号：US20220350854A1

公开(公告)日：2022-11-03

申请号：US17242770

申请日：2021-04-28

Applicant: IQVIA, INC.

Inventor： Gary Shorter ,  Jaffershah Jahangeer

IPC: G06F16/955 ,  G06K19/06 ,  G06K7/14 ,  G16H20/00

Abstract: Embodiments of the present disclosure provide a method for monitoring/tracking the lifecycle of a drug from build (e.g., as part of clinical trial development), to approval (e.g., regulatory), to in-market (e.g., distribution and safety information). The use of artificial intelligence (AI) and blockchain technology may enable the system to track the drug down to the prescription level and may support a digital label that can be updated as necessary based on such monitoring (e.g., that can be amended based on safety information detected while the drug is in market and warnings sent out upon amendment).

公开(公告)号：US12271435B2

公开(公告)日：2025-04-08

申请号：US18189393

申请日：2023-03-24

Applicant: IQVIA Inc.

Inventor： Gary Shorter ,  Jaffershah Jahangeer

IPC: G06F16/955 ,  G06K7/14 ,  G06K19/06 ,  G16H20/00

Abstract: Embodiments of the present disclosure provide a method for monitoring/tracking the lifecycle of a drug from build (e.g., as part of clinical trial development), to approval (e.g., regulatory), to in-market (e.g., distribution and safety information). The use of artificial intelligence (AI) and blockchain technology may enable the system to track the drug down to the prescription level and may support a digital label that can be updated as necessary based on such monitoring (e.g., that can be amended based on safety information detected while the drug is in market and warnings sent out upon amendment).